Corroborating this idea, the treatment of FF-fed Acsm3 KO mice with Adezmapimod resulted in an overall improvement in glucose metabolism, reduction of insulin resistance, diminished hepatic lipid deposition, and ballooning degeneration. This evidence concerns the gene ACSM3 and Insulin resistance.